380
Participants
Start Date
January 10, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2029
Intensity Modulated Radiation Therapy
All target volumes will be outlined slice by slice on the axial contrast-enhanced CT with MR fusion images in the treatment planning system. The target volumes are defined in accordance with the International Commission on Radiation Units and Measurements Reports 83. The prescribed dose is 70-72 Gy to PTVp (Planning target volume of the primary tumor), 64-70 Gy to PTVn (Planning target volume of the lymph node), 60- 64Gy to PTV1 (High-risk planning target volume), and 54-58 Gy to PTV2 (Low-risk planning target volume) in 30-32 fractions.
Chemotherapy
Induction chemotherapy: gemcitabine and cisplatin, Q3W, 3 cycles Concurrent chemotherapy: cisplatin, Q3W, 2-3 cycles
Immune checkpoint inhibitor
Cadonilimab: 10mg/kg, Q3W, 3 cycles
Low-dose radiotherapy
Low-dose radiotherapy will be performed to study group, with the use of IMRT.
Cancer Center, Sun Yat-sen University, Guangzhou
The First Affiliated Hospital of Guangxi Medical University, Nanning
Jiangxi Cancer Hospital, Nanchang
Sun Yat-sen University
OTHER